Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

People In Brief

This article was originally published in The Tan Sheet

Executive Summary

NPA’s former exec director joins CHPA; Henderson heads FDA’s women’s health office on permanent basis; Nestle promotes nutrition exec Goodyear; Bayer vet Lowinski leads Sanofi’s Asia region; more People In Brief.

You may also be interested in...



NPA Turns To Former Cement Lobbyist Shaw For Solid Leadership

The Natural Products Association names John Spitaleri Shaw executive director and CEO, nearly six months after the departure of his predecessor, John Gay. Shaw is a former senior VP at the Portland Cement Association and a newcomer to the consumer packaged goods industry.

NPA Turns To Former Cement Lobbyist Shaw For Solid Leadership

The Natural Products Association names John Spitaleri Shaw executive director and CEO nearly six months after the departure of his predecessor, John Gay. Shaw is a former senior VP at the Portland Cement Association and a newcomer to the consumer packaged goods industry.

In Brief

Shareholder suit against Johnson & Johnson, including CFO Caruso, may proceed; Novartis pauses OTC production at Nebraska plant; Mead Johnson finds Enfamil powder clear of bacteria after stores pull the product; John Gay leaves NPA after two years as executive director and CEO; more news In Brief.

Related Content

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

PS105624

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel